Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$127.73 - $147.2 $638 - $736
5 Added 0.16%
3,140 $431,000
Q4 2023

Jan 11, 2024

SELL
$92.79 - $142.53 $24,589 - $37,770
-265 Reduced 7.79%
3,135 $436,000
Q3 2023

Oct 12, 2023

BUY
$128.91 - $192.44 $9,023 - $13,470
70 Added 2.1%
3,400 $466,000
Q1 2023

Apr 07, 2023

BUY
$193.75 - $232.55 $2,906 - $3,488
15 Added 0.45%
3,330 $775,000
Q4 2022

Jan 11, 2023

BUY
$187.24 - $242.74 $3,744 - $4,854
20 Added 0.61%
3,315 $670,000
Q1 2022

Apr 06, 2022

BUY
$303.87 - $423.8 $51,657 - $72,046
170 Added 5.44%
3,295 $1.15 Million
Q4 2021

Jan 05, 2022

BUY
$347.28 - $421.83 $69,456 - $84,366
200 Added 6.84%
3,125 $1.19 Million
Q3 2021

Oct 04, 2021

SELL
$405.61 - $524.84 $6,084 - $7,872
-15 Reduced 0.51%
2,925 $1.19 Million
Q4 2020

Jan 25, 2021

BUY
$292.7 - $370.96 $117,080 - $148,384
400 Added 15.75%
2,940 $1.09 Million
Q3 2020

Oct 09, 2020

BUY
$268.51 - $400.74 $29,536 - $44,081
110 Added 4.53%
2,540 $785,000
Q4 2019

Feb 12, 2020

BUY
$288.29 - $335.49 $14,414 - $16,774
50 Added 2.1%
2,430 $806,000
Q3 2019

Oct 25, 2019

BUY
$266.84 - $378.23 $62,707 - $88,884
235 Added 10.96%
2,380 $724,000
Q2 2019

Aug 01, 2019

BUY
$300.59 - $368.15 $267,525 - $327,653
890 Added 70.92%
2,145 $790,000
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $99,447 - $133,787
365 Added 41.01%
1,255 $367,000
Q3 2018

Oct 30, 2018

BUY
$279.04 - $367.06 $94,873 - $124,800
340 Added 61.82%
890 $327,000
Q2 2018

Aug 01, 2018

BUY
$228.17 - $292.07 $82,141 - $105,145
360 Added 189.47%
550 $154,000
Q1 2018

May 10, 2018

BUY
$209.54 - $253.91 $8,381 - $10,156
40 Added 26.67%
190 $44,000
Q2 2017

Aug 22, 2017

BUY
N/A
150
150 $0

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Hall Laurie J Trustee Portfolio

Follow Hall Laurie J Trustee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

News

Stay updated on Hall Laurie J Trustee with notifications on news.